Shares of Momentus Inc. (MNTS) cratered 12.6% to $9.05 on June 22 as investors weighed the true cost of the space-transportation company's newly fortified balance sheet. The headline — $76 million in cash with no debt — sounds healthy. The fine print tells a different story: every dollar came from selling new stock, flooding the market with shares and shrinking existing investors' ownership stakes.
• The Cash Came From Printing Shares, Not Earning Revenue. Full use of a $50 million at-the-market (ATM) program — where a company quietly sells fresh shares into the open market — a $25 million private placement, and warrant exercises lifted cash to about $76 million with no debt. But shares outstanding ballooned from roughly 2.2 million in Q4 2025 to 10 million by the end of Q1 2026 , and stood at nearly 18.8 million after the latest offering . That means each existing share now represents a far smaller slice of the company.
• The Business Still Burns Far More Cash Than It Earns. Q1 2026 revenue was only about $3.2 million, with operating losses around -$8.9 million . Operating cash flow was roughly -$5.8 million in the quarter.
Management forecasts $10 million in full-year 2026 revenue — a ninefold jump over 2025's $1.1 million — driven by milestone-based NASA and Defense Department contracts. Even hitting that target leaves a wide gap between income and spending.
• The Growth Story Hinges on Government Contracts and a Single Mission. Momentus highlighted its Vigoride 7 orbital vehicle, launched aboard a SpaceX mission, now operating hosted payloads for NASA, DARPA, and defense customers.
SpaceX's upcoming IPO — potentially valued at up to $2 trillion — has lifted sentiment across space stocks , but Momentus's revenue depends on lumpy, milestone-based government payouts rather than recurring commercial income.
• Dilution Math Undermines the Valuation. At $9.05 with roughly 18.8 million shares outstanding, Momentus carries a market cap near $170 million — lofty for a company on track for just $10 million in revenue. The improved balance sheet is driven by equity raises, not business self-sufficiency , and if outstanding warrants or options are exercised, dilution will deepen further. Investors are effectively betting that capital raised today buys enough time for contracts to convert into real, scalable revenue — a leap of faith the market is currently repricing downward.